Enhancing therapies for MYC-overexpressing Non-Hodgkin's lymphoma: A role for MYC downregulation and new combination therapies

被引:0
|
作者
Psaras, Alexandra Maria [1 ]
Brooks, Tracy Ann [1 ]
机构
[1] Binghamton Univ, Johnson City, TN USA
关键词
D O I
10.1158/1538-7445.AM2020-653
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
653
引用
收藏
页数:2
相关论文
共 50 条
  • [1] New therapies in non-Hodgkin lymphoma
    Novelli, Silvana
    Sierra, Jorge
    Briones, Javier
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 349 - 359
  • [2] Antiangiogenic Therapies in Non-Hodgkin's Lymphoma
    Ruan, J.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (09) : 1030 - 1043
  • [3] Vaccine therapies for Non-Hodgkin’s Lymphoma
    Timmerman J.M.
    Current Treatment Options in Oncology, 2002, 3 (4) : 307 - 315
  • [4] Conventional treatments for non-Hodgkin's lymphoma: The need for new therapies
    Moskowitz, CH
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 2S - 10S
  • [5] Conventional treatments for non-Hodgkin's lymphoma: The need for new therapies
    White, CA
    Wiseman, G
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (11) : 1967 - 1968
  • [6] Novel therapies for non-Hodgkin Lymphoma
    Vose, Julie M.
    ANNALS OF ONCOLOGY, 2015, 26 : 17 - 17
  • [7] Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas
    Landsburg, Daniel J.
    Koike, Alexa
    Nasta, Sunita D.
    Svoboda, Jakub
    Schuster, Stephen J.
    Wasik, Mariusz A.
    Caponetti, Gabriel C.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 869 - 874
  • [8] Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas
    Daniel J. Landsburg
    Alexa Koike
    Sunita D. Nasta
    Jakub Svoboda
    Stephen J. Schuster
    Mariusz A. Wasik
    Gabriel C. Caponetti
    Cancer Immunology, Immunotherapy, 2021, 70 : 869 - 874
  • [9] Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma
    Banerjee, Titas
    Vallurupalli, Anusha
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [10] Precision therapies take aim at non-Hodgkin’s lymphoma
    Elie Dolgin
    Nature, 2018, 563 (7731) : S46 - S47